Sympathetic activation in heart failure

被引:31
|
作者
Gronda, E. [1 ,2 ]
Dusi, V [3 ]
D'Elia, E. [4 ]
Iacoviello, M. [2 ,5 ]
Benvenuto, E. [2 ,6 ]
Vanoli, E. [7 ,8 ]
机构
[1] Osped Maggiore Policlin, UOC Nefrol Dialisi & Trapianto Renate Adulto, Dipartimento Med & Special Med, Programma Cardiorenale,Fdn IRCCS Ca Granda, Milan, Italy
[2] Assoc Nazl Med Cardiol Osped Italia, Area Cardiorenale Metab, Milan, Italy
[3] Univ Turin, Dept Med Sci, Cardiol Div, Turin, Italy
[4] Papa Giovanni XXIII Hosp, Cardiovasc Dept, Bergamo, Italy
[5] Univ Foggia, Dipartimento Sci Med & Chirurg, AOU Policlin Riuniti Foggia, SC Cardiol, Foggia, Italy
[6] UTIC Emodinam PO G Mazzini Teramo, UOC Cardiol, Teramo, Italy
[7] Univ Pavia, Dept Mol Med, Pavia, Italy
[8] Sacra Famiglia Hosp, Dept Med Cardiol & Rehabil, Erba, Italy
关键词
Heart failure; Autonomic nervous system; Baroreflex activation; NERVE GROWTH-FACTOR; MYOCARDIAL-INFARCTION; RATE-VARIABILITY; BAROREFLEX SENSITIVITY; NEURONS; RISK; DOGS; INNERVATION; ARRHYTHMIAS; MECHANISMS;
D O I
10.1093/eurheartjsupp/suac030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sympathetic activation has been long appreciated exclusively as a fundamental compensatory mechanism of the failing heart and, thus, welcome and to be supported. In the initial clinical phases of heart failure (HF), the sympathetic nervous system overdrive plays a compensatory function aimed at maintaining an adequate cardiac output despite the inotropic dysfunction affecting the myocardium. However, when the sympathetic reflex response is exaggerated it triggers a sequence of unfavourable remodelling processes causing a further contractile deterioration that unleashes major adverse cardiovascular consequences, favouring the HF progression and the occurrence of fatal events. Eventually, the sympathetic nervous system in HF was demonstrated to be a 'lethality factor' and thus became a prominent therapeutic target. The existence of an effective highly specialized intracardiac neuronal network immediately rules out the old concept that sympathetic activation in HF is merely the consequence of a drop in cardiac output. When a cardiac damage occurs, such as myocardial ischaemia or a primary myocardial disorder, the adaptive capability of the system may be overcame, leading to excessive sympatho-excitation coupled with attenuation till to abolishment of central parasympathetic drive. Myocardial infarction causes, within a very short time, both a functional and anatomical remodelling with a diffuse up-regulation of nerve growth factor (NGF). The subsequent nerve sprouting signal, facilitated by a rise in the levels of NGF in the left stellate ganglion and in the serum, triggers an increase in cardiac nerve density in both peri-infarct and non-infarcted areas. Finally, NFG production decreases over time, supposedly as an adaptative response to the prolonged exposure to sympathetic overactivity, leading in the end to a reduction in sympathetic nerve density. Accordingly, NGF levels were markedly reduced in patients with severe congestive heart failure. The kidney is the other key player of the sympathetic response to HF as it indeed reacts to under-perfusion and to loop diuretics to preserve filtration at the cost of many pathological consequences on its physiology. This vicious loop ultimately participates to the chronic and disruptive sympathetic overdrive. In conclusion, sympathetic activation is the natural physiological consequence to life stressors but also to any condition that may harm our body. It is the first system of reaction to any potential life-threatening event. However, in any aspect of life over reaction is never effective but, in many instances, is, actually, life threatening. One for all is the case of ischaemia-related ventricular fibrillation which is, strongly facilitated by sympathetic hyperactivity. The take home message? When, in a condition of harm, everybody is yelling failure is just around the corner.
引用
收藏
页码:E4 / E11
页数:8
相关论文
共 50 条
  • [1] Sympathetic activation in chronic heart failure
    Noble, MIM
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 73 (02) : 163 - 164
  • [2] Mechanisms of sympathetic activation in heart failure
    Watson, A. M. D.
    Hood, S. G.
    May, C. N.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (12) : 1269 - 1274
  • [3] Central and peripheral sympathetic activation in heart failure
    Grassi, Guido
    Mancia, Giuseppe
    Esler, Murray
    CARDIOVASCULAR RESEARCH, 2022, 118 (08) : 1857 - 1871
  • [4] The effect of obesity on sympathetic activation in heart failure
    Dao, Christine N.
    Fonarow, Gregg C.
    Hamilton, Michele
    Middlekauff, Holly R.
    Horwich, Tamara B.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S34 - S35
  • [5] SYMPATHETIC ACTIVATION IN CONGESTIVE HEART-FAILURE
    MANCIA, G
    EUROPEAN HEART JOURNAL, 1990, 11 : 3 - 11
  • [6] Sympathetic activation in congestive heart failure: an updated overview
    Grassi, Guido
    Quarti-Trevano, Fosca
    Esler, Murray D.
    HEART FAILURE REVIEWS, 2021, 26 (01) : 173 - 182
  • [7] Sympathetic activation in heart failure: A target of therapeutic approaches
    P. Schnabel
    M. Böhm
    Zeitschrift für Kardiologie, 1999, 88 (Suppl 3): : S005 - S011
  • [8] Sympathetic nerve activation in heart failure and iron deficiency
    Baker, R. Richard
    Adams, Z. H.
    Hope, K. A.
    Hart, E. C.
    Nightingale, A. K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 169 - 170
  • [9] Sympathetic activation in heart failure:: A target of therapeutic approaches
    Schnabel, P
    Böhm, M
    ZEITSCHRIFT FUR KARDIOLOGIE, 1999, 88 : 5 - 11
  • [10] EXCESSIVE SYMPATHETIC ACTIVATION IN HEART FAILURE ASSOCIATED WITH ANEMIA
    Franchitto, N.
    Despas, F.
    Labrunee, M.
    Boveda, S.
    Galinier, M.
    Senard, J. M.
    Pathak, A.
    JOURNAL OF HYPERTENSION, 2010, 28 : E528 - E528